USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
DIAGNOSTIC PHOTONICS, INC.
Address:
200 South Wacker Drive
CHICAGO, IL 60606-2901
EIN:
126353825
DUNS:
829708903
Number of Employees:
5
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $796,867.00 4
SBIR Phase II $1,852,379.00 1

Award List:

Noninvasive 3-D optical quantitative imaging of engineered tissue

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$149,991.00
Agency:
DOD
Principal Investigator:
Andrew Citadine, President and CEO – (312) 320-5478
Abstract:
This project will bring interferometric synthetic aperture microscopy (ISAM), a powerful new method of computed microscopy, to bear on the problem of quantitative tissue assessment. The promise of tissue engineering, including wound healing, is limited unless the tissue is treated correctly at… More

Computed Optical Margin Assessment for Breast Cancer

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$299,973.00
Agency:
HHS
Principal Investigator:
Andrew J. Cittadine – 312-320-5478
Abstract:
DESCRIPTION (provided by applicant): Diagnostic Photonics, Inc. (DxP) is a medical device company developing an intraoperative imaging system for surgical guidance and real-time assessment of cancer tumor margins based on interferometric synthetic aperturemicroscopy (ISAM), a novel modality that… More

IGF::OT::IGF OTHER FUNCTIONS AUTOMATED DATA SEGMENTATION TO ENABLE REAL-TIME IN VIVO 3-D IMAGE RECONSTRUCTION

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$197,428.00
Agency:
HHS
Principal Investigator:
Andrew Cittadine – 312-320-5478
Abstract:
In vivo medical imaging is becoming an indispensable tool in the screening, diagnosis, staging, treatment, and monitoring of cancer and a host of other diseases. However, the full potential of these technologies has been severely limited by image processing time and memory management of large data… More

Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$149,475.00
Agency:
HHS
Principal Investigator:
Adam M. Zysk – 312-857-6766
Abstract:
DESCRIPTION (provided by applicant): Diagnostic imaging in modern dental practice still relies mainly on visual inspection or x-ray radiography, a technology that remains largely unchanged since the late 1800s. The early detection of small caries and the evaluation of microscopic enamel cracks prior… More

Computed Optical Margin Assessment for Breast Cancer

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,852,379.00
Agency:
HHS
Principal Investigator:
Andrew J. Cittadine – 312-320-5478
Abstract:
DESCRIPTION (provided by applicant): Diagnostic Photonics, Inc. (DxP) is a medical device company developing an intraoperative imaging system for surgical guidance and real-time assessment of cancer tumor margins based on interferometric synthetic aperturemicroscopy (ISAM), a novel modality that… More